Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
BioLine RX (BLRX US)
Watchlist
12
Analysis
Health Care
•
Israel
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
BioLine RX
•
26 Nov 2025 05:00
•
Issuer-paid
BLRX: Stem Cell Mobilization Presentation at ASH
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
165 Views
Share
bullish
•
BioLine RX
•
01 Oct 2025 01:00
•
Issuer-paid
BLRX: A Venture into GBM
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
278 Views
Share
bullish
•
BioLine RX
•
16 Aug 2025 04:00
•
Issuer-paid
BLRX: ASCO Poster & Abstract
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
382 Views
Share
bullish
•
BioLine RX
•
03 Jun 2025 03:00
•
Issuer-paid
BLRX: First Quarter Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
237 Views
Share
bullish
•
BioLine RX
•
28 May 2025 22:00
•
Issuer-paid
BLRX: First Quarter Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
234 Views
Share
1
2
3
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x